Data Integrity Considerations When Handling OOS Results in Stability Testing
In pharmaceutical stability testing, Out-of-Specification (OOS) results demand more than just technical investigation — they require impeccable data integrity. With global regulatory agencies such as the USFDA, EMA, and CDSCO tightening their scrutiny on data handling practices, ensuring that all OOS-related documentation adheres to ALCOA+ principles has become critical for pharma professionals. This article provides…
Read More “Data Integrity Considerations When Handling OOS Results in Stability Testing” »